Handling Missing Data in a Duloxetine Population Pharmacokinetic/Pharmacodynamic Model – Imputation Methods and Selection Models
暂无分享,去创建一个
[1] Ivelina Gueorguieva,et al. Population pharmacokinetic/pharmacodynamic models for duloxetine in the treatment of diabetic peripheral neuropathic pain , 2013, European journal of pain.
[2] M. Heathman,et al. Population Pharmacokinetics of Orally Administered Duloxetine in Patients , 2012, Clinical pharmacokinetics.
[3] R T O'Neill,et al. The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It , 2012, Clinical pharmacology and therapeutics.
[4] An Vermeulen,et al. Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders , 2011, Clinical pharmacokinetics.
[5] S. Bongardt,et al. Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens , 2009, The Clinical journal of pain.
[6] M. Man-Son-Hing,et al. Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review , 2009, Open medicine : a peer-reviewed, independent, open-access journal.
[7] R. Gomeni,et al. Modelling placebo response in depression trials using a longitudinal model with informative dropout. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] P. Lane. Handling drop‐out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches , 2008, Pharmaceutical statistics.
[9] L. Hunt,et al. Missing Data in Clinical Studies , 2007 .
[10] J. Wernicke,et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain , 2006, Neurology.
[11] Smriti Iyengar,et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. , 2005, Pain medicine.
[12] M. Detke,et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.
[13] E. Whalen,et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens , 2005, Pain.
[14] Jack A. Cook,et al. The Use of Clinical Trial Simulation to Support Dose Selection: Application to Development of a New Treatment for Chronic Neuropathic Pain , 2003, Pharmaceutical Research.
[15] Geert Molenberghs,et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data , 2003, Biological Psychiatry.
[16] Mark E. Sale,et al. A Joint Model for Nonlinear Longitudinal Data with Informative Dropout , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[17] D. Fairclough. Design and analysis of quality of life studies in clinical trials , 2002, Quality of Life Research.
[18] A Lawrence Gould,et al. COMPARISON OF ALTERNATIVE STRATEGIES FOR ANALYSIS OF LONGITUDINAL TRIALS WITH DROPOUTS , 2002, Journal of biopharmaceutical statistics.
[19] J. Farrar,et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.
[20] James Lindsey. DROPOUTS IN LONGITUDINAL STUDIES: DEFINITIONS AND MODELS , 2000, Journal of biopharmaceutical statistics.
[21] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[22] J. Schafer. Multiple imputation: a primer , 1999, Statistical methods in medical research.
[23] Adrian Dunne,et al. Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials , 1997 .
[24] D. Spiegelhalter,et al. Bayesian Analysis of Realistically Complex Models , 1996 .
[25] Peter J. Diggle,et al. Testing for random dropouts in repeated measurement data. , 1989 .
[26] M. Heathman,et al. Erratum to: Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation , 2009 .
[27] R. Woolson,et al. Substance Abuse Treatment, Prevention, and Policy a Comparison of Missing Data Methods for Hypothesis Tests of the Treatment Effect in Substance Abuse Clinical Trials: a Monte-carlo Simulation Study , 2007 .
[28] O Siddiqui,et al. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts. , 1998, Journal of biopharmaceutical statistics.
[29] P. Diggle,et al. Testing for random dropouts in repeated measurement data. , 1989, Biometrics.